NovAb
Founded 2013
About NovAb
NovAb is a biotechnology company developing therapeutic drugs, diagnostic reagents, and biomedical research reagents. Its biotechnology platform utilizes Variable Lymphocyte Receptors to develop therapeutic drugs. It also produces monoclonal VLR antibodies specific for novel targets, including a plasma cell-restricted cell surface target that is the basis for therapies for multiple myeloma, autoimmune disease, and transplant rejection. In addition, the company develops a new class of high-sensitivity polymeric antibody diagnostic reagents that target the detection of infectious agents and a new category of research reagents that recognize glycans and distinguish closely related glycan structures.
Company Facts
- Founded: 2013
- Legal name: NovAb, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: novabinc.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/novab-8404430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.